Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results

BACKGROUND: World Health Organization expert groups recommended mortality trials of four repurposed antiviral drugs - remdesivir, hydroxychloroquine, lopinavir, and interferon beta-1a - in patients hospitalized with coronavirus disease 2019 (Covid-19). METHODS: We randomly assigned inpatients with C...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autor principal:	Alvarez Manrique, Victor Daniel
Formato:	Artículo
Lenguaje:	inglés
Publicado:	2020
Materias:	Coronavirus disease 2019 (COVID-19) Interim Solidarity 2019-20 coronavirus outbreak Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Virology Medicine Political science Internal medicine Law Outbreak Disease Politics Infectious disease (medical specialty) Interferon beta-1a therapeutic use COVID-19 mortality COVID-19 Drug Treatment Adenosine Monophosphate analogs & derivatives Adenosine Monophosphate therapeutic use Aged Alanine analogs & derivatives Alanine therapeutic use Antiviral Agents administration & dosage Antiviral Agents adverse effects Antiviral Agents therapeutic use Drug Therapy, Combination Female Hospitalization Humans Hydroxychloroquine therapeutic use Length of Stay Male Middle Aged Respiration, Artificial Hospital Mortality Treatment Failure Kaplan-Meier Estimate Intention to Treat Analysis Lopinavir therapeutic use Health Sciences Medicine Infectious Diseases COVID-19 Clinical Research Studies Health Sciences Medicine Infectious Diseases SARS-CoV-2 and COVID-19 Research Life Sciences Biochemistry, Genetics and Molecular Biology Molecular Biology Pharmacological Receptor Mechanisms and Effects
Acceso en línea:	Ver en el sistema de origen Ver en el sistema de origen Enlace permanente (DOI o Handle)
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Sea el primero en dejar un comentario!

Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results

Ejemplares similares